Abstract

Several studies suggest that HTLV-1 infection may be associated with a wider spectrum of neurologic manifestations that do not meet diagnostic criteria for HAM/TSP. These conditions may later progress to HAM/TSP or constitute an intermediate clinical form, between asymptomatic HTLV-1 carriers and those with full myelopathy. Our aim was to determine the prevalence of HTLV-1-associated disease in subjects without HAM/TSP, and the relationship between these findings with HTLV-1 proviral load (PVL). Methods: 175 HTLV-1-infected subjects were submitted to a careful neurological evaluation, during their regular follow up at the HTLV outpatient clinic of the Institute of Infectious Diseases “Emilio Ribas”, São Paulo city, Brazil. Clinical evaluation and blinded standardized neurological screening were performed for all the subjects by the same neurologist (MH). Results: After the neurological evaluation, 133 patients were classified as asymptomatic and 42 fulfilled the criteria for intermediate syndrome (IS). The mean age of the enrolled subjects was 46.3 years and 130 (74.3%) were females. Clinical classification shows that neurological symptoms (p<0.001), visual disorders (p = 0.001), oral conditions (p = 0.001), skin lesions (p<0.001), bladder disorders (p<0.001), and rheumatological symptoms (p = 0.001), were strongly associated to IS, except for disautonomy (p = 0.21). A multivariate analysis revealed that HTLV-1 proviral load, oral conditions, bladder disorders and rheumatological symptoms were independently associated with the IS. Conclusions: We found some early alterations in 42 patients (24%), particularly the presence of previously not acknowledged clinical and neurological symptoms, among subjects previously classified as "asymptomatic", who we reclassified as having an intermediate syndrome.

Highlights

  • Human T-Cell Lymphotropic Virus type 1 (HTLV-1), a human retrovirus, is the causative agent of Adult T Leukemia/Lymphoma (ATLL) and HTLV-1-associated myelopathy (HAM/TSP)[1], at least 5–10 million people infected worldwide, almost 5–10% of them in Brazil [2]

  • At least 5–10 million people live with the Human T-Cell Lymphotropic Virus type 1 (HTLV-1) worldwide, and around 0.25–5% of them may develop HTLV-1-associated myelopathy/Tropical spastic paraparesis (HAM/TSP), which is associated with chronic inflammation

  • In this study, involving 175 HTLV-1-infected subjects originally classified as asymptomatic, we found that 42 of them in reality presented some early clinical conditions, including alterations related to the neurological system, and to the eyes and the skin

Read more

Summary

Introduction

HTLV-1, a human retrovirus, is the causative agent of Adult T Leukemia/Lymphoma (ATLL) and HTLV-1-associated myelopathy (HAM/TSP)[1], at least 5–10 million people infected worldwide, almost 5–10% of them in Brazil [2]. High, such numbers may be an underestimate since only 2/3 of the world has been mapped for HTLV infection [3]. HTLV-1 has been shown to be associated with HAM/TSP and with several inflammatory diseases, such as alveolitis, polymyositis, arthritis, infective dermatitis, Sjogren syndrome and uveitis [5,6,7,8,9]. Despite the fact that few patients (

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call